Riskpilot← Back to searchSign inGet full accessAscop Oy
OYDissolvedY-tunnus 2641086-8Mustasaarenlehto 1-BMedical specialists activities · NACE 8622Est. 20141 employees
Revenue 2024
EUR 321K
-99% vs 2023
EBITDA margin
48.7%
-99% vs 2023
Equity ratio
27.8%
Financial strength
Net profit 2024
EUR 151K
-99% vs 2023
| Revenue | EUR 321K | -99% |
| EBITDA | EUR 156K | -99% |
| Net profit | EUR 151K | -99% |
| Total assets | EUR 556K | +7% |
| Equity | EUR 155K | +25% |
| Employees | 1 | — |
Legal name
Ascop Oy
Y-tunnus number
2641086-8
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
12. syyskuuta 2014
Share capital
EUR 2 500
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen jäsenet ja toimitusjohtaja kukin yksin
Company purpose
Yhtiön toimialana on lääkäripalvelujen tarjoaminen. Yhtiö voi omistaa, hallita, ostaa, myydä ja vuokrata kiinteistöjä, osakehuoneistoja, osakkeita ja arvopapereita omaan lukuunsa sekä harjoittaa muuta sijoitustoimintaa.
Address
Mustasaarenlehto 1-B
Phone
+3580405955597
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 230 | 285 | 292 | 29 070 | 321 |
| Staff expenses | −21 | −30 | −52 | −5 457 | −46 |
| EBITDA | 141 | 183 | 155 | 14 175 | 156 |
| Depreciation & amort. | −9 | −0 | — | −0 | 2 |
| EBIT | 131 | 183 | 155 | 14 175 | 159 |
| Net financials | −3 | −1 | −21 | 452 | 24 |
| Profit before tax | 128 | 182 | 134 | 14 627 | 183 |
| Tax | 26 | 38 | 31 | 30 | 32 |
| Net profit | 103 | 144 | 103 | 11 645 | 151 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 439 | 452 | 435 | 518 | 556 |
| Equity | 210 | 244 | 128 | 124 | 155 |
| Long-term debt | 186 | 177 | 156 | 241 | 214 |
| Short-term debt | 44 | 32 | 152 | 153 | 188 |
| Total debt | 230 | 208 | 308 | 394 | 402 |
EBITDA margin
48.7%
This company
15.8%
Market median
+208% vs market
20202024
Equity ratio
27.8%
This company
38.2%
Market median
-27% vs market
20202024
Return on equity
97.4%
This company
18.4%
Market median
+429% vs market
20202024
Net profit margin
46.9%
This company
8.1%
Market median
+479% vs market
20202024
Asset turnover
0.58×
This company
1.12×
Market median
-48% vs market
20202024
Debt / equity
2.60×
This company
0.62×
Market median
-319% vs market
20202024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
TJ Deputy auditor | Deputy auditor | 2021 |
JS | Audit | 2021 |
JS Chief Executive Officer | Chief Executive Officer | 2014 |
HM Deputy Member | Deputy Member | 2014 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
JoHan Invest Oy
Ascop Oy Board members of Ascop Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Timo Jaakko Ollila | Deputy auditor | 0 companies |
| Janne-Tuomas Seppänen | Audit | 0 companies |
| Johannes Sakari Luukkonen | Chief Executive Officer | 0 companies |
| Hanna Maria Luukkonen | Deputy Member | 0 companies |